Your browser doesn't support javascript.
loading
Atherosclerosis and Cardiovascular Diseases in Progeroid Syndromes.
Kato, Hisaya; Maezawa, Yoshiro.
Affiliation
  • Kato H; Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine.
  • Maezawa Y; Division of Diabetes, Metabolism and Endocrinology, Chiba University Hospital.
J Atheroscler Thromb ; 29(4): 439-447, 2022 Apr 01.
Article in En | MEDLINE | ID: mdl-34511576
ABSTRACT
Hutchinson-Gilford progeria syndrome (HGPS) and Werner syndrome (WS) are two of the representative genetic progeroid syndromes and have been widely studied in the field of aging research. HGPS is a pediatric disease in which premature aging symptoms appear in early childhood, and death occurs at an average age of 14.5 years, mainly due to cardiovascular disease (CVD). Conversely, WS patients exhibit accelerated aging phenotypes after puberty and die in their 50s due to CVD and malignant tumors. Both diseases are models of human aging, leading to a better understanding of the aging-associated development of CVD. In this review, we discuss the pathogenesis and treatment of atherosclerotic diseases presented by both progeroid syndromes with the latest findings.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Progeria / Werner Syndrome / Cardiovascular Diseases / Atherosclerosis Type of study: Prognostic_studies Limits: Child, preschool / Humans Language: En Journal: J Atheroscler Thromb Journal subject: ANGIOLOGIA Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Progeria / Werner Syndrome / Cardiovascular Diseases / Atherosclerosis Type of study: Prognostic_studies Limits: Child, preschool / Humans Language: En Journal: J Atheroscler Thromb Journal subject: ANGIOLOGIA Year: 2022 Type: Article